readthroughSign in
CompanyTENXNasdaqChapel Hill, NC

Tenax Therapeutics, Inc.

Tenax Therapeutics develops levosimendan, a K-ATP channel activator/calcium sensitizer.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 5Latest story